SLDB Solid Biosciences Inc.
$8.70▼ -4.08%
Healthcare
Other
After hours
$8.87▲ +1.95%
Sep 11, 7:59 PM ET
Volume 1.11M
Avg Volume (10D) 746.2K
Key Metrics & Fundamentals
Market Cap
$932.86M
P/E Ratio
–
Div Yield
–%
52W Range
3.79 - 11.45
% vs 50 MA
-6.15%
% vs 200 MA
17.44%
RSI-14
41.1
MACD Histogram
-0.1300
Beta (1Y vs SPY)
2.06
Free Cash Flow
-$52.74M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$53.56M
COGS
–
Operating Exp
$57.38M
Operating Income
-$57.38M
EBIT
-$57.38M
Pretax Income
-$54.80M
Net Income
-$54.80M
EPS (Diluted)
-0.38
Price & Volume History
Loading chart…
Recent News
Solid Biosciences to Participate at Upcoming Investor Conferences
GlobeNewswire · Sep 2, 2026 12:00 PM
Wedbush Adjusts PT on Solid Biosciences to $15 From $16, Maintains Outperform Rating
MT Newswires · Aug 7, 2026 3:02 PM
Solid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire · Aug 6, 2026 8:08 PM
Does Solid Biosciences' (SLDB) Russell Growth Index Debut Reveal a Shift in Its Investor Base?
Simply Wall St. · Jul 2, 2026 3:28 AM
Sarepta's Elevidys Showing Signs of Stabilization as siRNA Pipeline Gains Importance, RBC Says
MT Newswires · Jun 18, 2026 3:04 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See SLDB's money flow as a full page
Social Sentiment
No Reddit posts found for SLDB.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.